Year archive

Jamjoom Pharmaceuticals Factory Co. — 2023 filings

All 9 regulatory filings released by Jamjoom Pharmaceuticals Factory Co. (4015) in 2023, sourced directly from the official regulator.

9 Filings

2023 Period

2023 filings (9)

Filing	Released	Lang
Jamjoom Pharmaceuticals Factory Company announces providing a corporate guarantee to its Joint Venture in Algeria Capital/Financing Update	2023-11-22	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial Results for the Period Ending on 2023-09-30 (Nine Months) Interim / Quarterly Report	2023-11-07	English
Jamjoom Pharmaceuticals Factory Co. announces its intention to release its interim financial results for the period ended 30 September 2023 (Nine Months) on Tuesday, November 7, 2023, before the tradi Report Publication Announcement	2023-11-01	English
Jamjoom Pharmaceuticals Factory Co. announces the distribution of cash dividend for first half of the year 2023 Notice of Dividend Amount	2023-08-10	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial Results for the Period Ending on 2023-06-30 ( Six Months ) Interim / Quarterly Report	2023-08-10	English
Jamjoom Pharmaceuticals Factory Co. announces that it will conduct an Earnings Call to discuss the financial results of the Q2-2023 with investors and financial analysts Call Transcript	2023-08-03	English
Jamjoom Pharmaceuticals Factory Co. announces an increase in the capital of its Joint Venture in Algeria to partially fund the acquisition of a pharmaceutical manufacturing factory Capital/Financing Update	2023-07-31	English
Jamjoom Pharmaceuticals Factory Co. Announces Resignation and Appointment of a Board Member Board/Management Information	2023-07-04	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial Results for the Period Ending on 2023-03-31 ( Three Months ) Interim / Quarterly Report	2023-07-02	English